A dental group is usually run on two instincts: deliver good clinical care, and watch the top-line revenue. Both are reasonable, and neither tells the owner where the group's economics actually live. The money in a dental group is decided in two specific places that the top line does not show and most dental software does not instrument: how much of the constrained chair time is converted into yielding work, and how much clinically identified treatment travels the distance from a plan on a screen to completed, paid, repeated care. A group can have strong revenue and still be leaking heavily in both, and not see it, because the two levers that determine its economics are the two it does not measure.
This piece is a perspective on where a dental group's economics genuinely sit and why they are typically uninstrumented. The argument is opinionated. We are not arguing that clinical quality or revenue do not matter, or that dentists should sell treatment. We are arguing that group economics are governed by chair utilisation and the treatment-plan funnel; that most dental software tracks appointments and billed items but not the chair as a yielding asset or the plan as a tracked object through acceptance, scheduling, completion, and recall; and that this leaves the two real levers running blind while the group optimises the things it can see. Multi-branch operation multiplies the effect, because each site leaks its own way and the group only sees the sum.
The audience for this analysis is owners and operators of UAE dental groups who deliver good clinical care, watch revenue, and still feel the economics are softer than the clinical work should produce. The useful diagnostic question is not "what was our revenue" but "what is our case-acceptance rate by clinician and site, what is our accepted-but-undelivered plan value right now, and what is our chair utilisation, and can we answer any of those without a manual exercise".
The Treatment-Plan Funnel, Stage by Stage
Below is the treatment-plan funnel a dental group actually runs, from a plan being presented through to a patient returning, with the chair-utilisation lever sitting inside it where acceptance turns into delivered work. The point is not that drop-off is avoidable; some always is. The point is that each narrowing is an economic event, that the largest of them is invisible without instrumenting the plan and the chair, and that most dental software measures the appointment and the bill rather than either of these. Tap any stage for where the economics leak there and what most dental software misses.
The treatment-plan funnel, where the economics leak, and what software misses
Tap any stage for the economic leak and the instrumentation gap
Why the Economics Live Here and Not in the Top Line
The reason the top line hides this is that revenue is an outcome of the funnel, not a view of it. Top-line revenue can be flat while case acceptance has fallen and chair utilisation has risen to compensate, or strong while accepted plans are quietly decaying unscheduled. The number that aggregates everything tells the owner the result and nothing about the two levers that produced it, which is why a group can be clinically excellent and economically soft at the same time and have no instrument that explains the gap.
The UAE dental market makes both levers sharp. There were around 75 licensed dental clinics among Dubai's 5,372 facilities in 2024, many of them operating as multi-branch groups, in a market where Dubai health spending was about AED 22.24 billion in 2023 with roughly 61 per cent privately financed. A large share of dentistry is elective and privately funded, which makes case acceptance highly variable and highly consequential: the same clinically indicated plan can be accepted or declined depending on clinician, presentation, and follow-up, and every decline is identified clinical work and lost revenue simultaneously. Private-pay elective demand is exactly the condition under which the acceptance lever moves the most money.
The chair makes the second lever physical. Unlike many healthcare settings, dentistry has a hard, visible constrained asset: the chair. Chair time is finite and idle chair time is unrecoverable, so the yield of the time used, not just whether it was used, governs the economics. A group that treats the diary as a calendar rather than the chair as a yielding asset cannot see whether high-value accepted work is being delivered or is waiting while low-yield time is booked. Multi-branch operation multiplies both levers, because acceptance and utilisation vary by site and the group only ever sees the consolidated total, which is the one number that cannot tell it which site or clinician to look at.
The shift in one observation
A dental group's economics are not in the revenue figure; they are in two levers the revenue figure hides: how much clinically identified treatment converts through acceptance, scheduling, delivery, completion, and recall, and how much of the constrained chair time becomes yielding work. Most dental software measures the appointment and the bill, which are downstream of both levers. The group is steering on the outcome while the two controls that produce it are uninstrumented.
Where the Group Leaks
The uninstrumented model leaks dental group economics in four predictable places.
Acceptance that is never measured
Case-acceptance rate by clinician, plan type, and site is the most diagnostic number a dental group has, and the one most often missing. Without it the group cannot tell strong acceptance it could learn from from weak acceptance it should address, so the largest economic event in the funnel is managed by feel.
Accepted plans that decay unscheduled
An accepted plan that is not promptly scheduled cools. The hard part, the patient saying yes, was already won, and the value then expires between the yes and the chair. Few systems track accepted-but-unscheduled plan value as a live figure, so no one is accountable for converting agreed revenue into booked revenue.
Chair time treated as a calendar
When the diary is managed as a calendar rather than the chair as a yielding asset, idle and low-yield chair time is invisible while high-value accepted work waits. Utilisation and yield by chair, clinician, and site is the second economic lever, and treating it as scheduling rather than asset management leaves it unmanaged.
Completion and recall left to intention
Stalled multi-visit plans and uncalled recall lists convert relationships into single transactions and leave started work unfinished. Completion as a tracked state and recall as a measured engine are frequently absent, so the group cannot see its incomplete-plan liability or the returning revenue it is forgoing.
The Numbers
Two Ways to Run a Dental Group
The difference between dental groups whose economics match their clinical quality and those whose do not is whether the two real levers are instrumented.
| Dimension | Top-line and diary | Instrumented levers |
|---|---|---|
| The plan | Recorded only as appointments and billed items. | Tracked as an object through acceptance, scheduling, completion. |
| Case acceptance | Unmeasured. Managed by feel. | Measured by clinician, plan type, and site, and managed. |
| The chair | A calendar to fill. | A yielding asset, utilisation and yield measured. |
| Accepted-undelivered | Invisible. Decays unscheduled. | A live figure someone is accountable for converting. |
| Recall | An intention. A list no one works. | A measured engine that amortises the relationship. |
| Multi-branch | Only the consolidated total is visible. | Per-site and per-clinician, so the leak is locatable. |
A dental group can be clinically excellent and economically soft at the same time, because clinical quality and the top line are not the levers that decide its economics. Case acceptance and chair yield are, and a group that measures appointments and bills rather than those two is steering on the outcome while the controls that produce it run blind.
What an Instrumented Dental Group Looks Like
The pattern in dental groups whose economics match their clinical quality is recognisable. The treatment plan is a tracked object, not just a set of appointments, so presentation and acceptance are measured by clinician, plan type, and site. Accepted-but-undelivered plan value is a live figure someone owns and converts, rather than something that decays unscheduled. The chair is managed as a yielding asset, with utilisation and the yield of the time used visible by chair, clinician, and site. Plan completion is a tracked state, so stalled multi-visit plans are surfaced and recovered rather than written off by silence. Recall is a measured engine that amortises the relationship rather than an intention attached to a list no one works. And because all of this is per-site and per-clinician, the group can locate a leak rather than only see its total.
This does not necessarily mean replacing the practice-management system already in place. In many groups the plan tracking, acceptance measurement, and chair-yield instrumentation can be built around the existing system, provided it can hold the plan as an object and expose the diary as an asset rather than only a calendar. Replacement becomes the better option mainly where the existing system structurally cannot represent the plan funnel or chair yield. Which applies is specific to the systems in place and the branch structure, and is established in scoping before any build commitment.
How This Sits Alongside the Group's Own Clinical Work
The configuration keeps a clear separation. The dental group delivers the clinical care, employs and licenses its dentists, makes every clinical and treatment-planning determination, owns its patient and payer relationships, and is responsible for its own clinical and regulatory obligations. The software is the instrumentation: the plan as a tracked object, acceptance and completion measurement, and chair utilisation and yield.
This is the role BY BANKS is positioned for. We are an independent software engineering company based in the UAE. We design and build software and hand it over to the group that runs it. We do not deliver dentistry, we do not make clinical or treatment-planning determinations, we do not direct what should be presented to a patient, we are not a regulated healthcare entity, and we are not affiliated with any authority. The group owns the clinical care, the treatment decisions, and its own compliance; we build the system that makes the economic levers visible so the group can manage them. The accountable party leads and owns the obligations; we build to their direction.
Where This Analysis Is Useful
The conversations where this perspective is most useful tend to be at three moments: an owner whose clinical quality is high but whose economics feel softer than they should be; a group that cannot state its case-acceptance rate by clinician and site or its accepted-but-undelivered plan value; or an operator whose chairs feel busy while yield is flat and who suspects the diary is being filled rather than the asset managed. The honest answer is usually the same: the economics live in acceptance and chair yield, not the top line, and a group that does not instrument those two is managing the result instead of the levers.
For broader related work, see our perspective on why claims in Dubai are decided at the point of care and our perspective on the cost of running a Dubai clinic group on single-site systems. The applied work sits across our dental clinic software capability, within the broader healthcare software practice and our operational platforms work. Get in touch if a 45-minute conversation about a specific dental group would be useful.
Frequently Asked Questions
No. The argument is about visibility, not pressure. What to present to a patient is a clinical determination that belongs entirely to the dentist, and nothing here changes that. Measuring case acceptance lets a group see where clinically indicated treatment is and is not converting, learn from strong practice, and address weak conversion through better presentation and follow-up. It does not, and should not, push clinicians toward treatment that is not clinically indicated; that judgement remains the clinician's.
No. We are an independent software engineering company based in the UAE. We design and build software and hand it over to the group that runs it. We do not deliver dentistry, we do not make clinical or treatment-planning determinations, and we are not a regulated healthcare entity. On any engagement, the group owns the clinical care, the treatment decisions, the patient relationships, and its own compliance. We build the system that makes the economic levers visible; the group exercises clinical and commercial judgement.
The multi-branch case multiplies the effect, because acceptance and utilisation vary by site and only the total is visible, but both levers govern a single practice too. A single practice still has a constrained chair and a treatment-plan funnel, and instrumenting acceptance, accepted-undelivered value, utilisation, completion, and recall improves the economics regardless of scale. The group case is more acute, not different in kind.
Often not. In many groups the plan tracking, acceptance measurement, and chair-yield instrumentation can be built around the practice-management system already in place, provided it can hold the plan as an object and expose the diary as an asset rather than only a calendar. Replacement becomes the better option mainly where the existing system structurally cannot represent the plan funnel or chair yield. Which applies is specific to the systems in place and is established in scoping before any build commitment.
It is sequenced and does not require pausing the practice. The usual starting point is making the plan a tracked object and measuring case acceptance by clinician and site, because that is the largest and least visible economic event. Accepted-but-undelivered value and chair yield follow, then completion tracking and a managed recall engine. The order is driven by where the largest unmeasured leak currently sits, which scoping establishes for the specific group.
A dental group's economics are widely assumed to be visible in clinical quality and the top line, and are in fact decided in two levers neither of those shows: how much clinically identified treatment converts through the plan funnel, and how much of the constrained chair time becomes yielding work. Most dental software measures appointments and bills, which are downstream of both, so the group steers on the outcome while the controls run blind, and multi-branch operation multiplies it. The groups whose economics match their clinical quality are the ones that instrumented acceptance and chair yield per clinician and site. The build is software work; the clinical care, the treatment determinations, and the group's regulatory obligations remain entirely the group's, and the system simply makes the levers visible so they can be managed rather than felt.
References to the Dubai dental and healthcare market are descriptive of publicly available information. The facility and funding figures cited (approximately 75 licensed dental clinics among Dubai's 5,372 facilities in 2024, and Dubai health spend of approximately AED 22.24 billion in 2023 with around 61% privately financed) are drawn from public sources listed on our Sources and Data page; the funnel and its shape are an observational model rather than measured statistics, and represent no specific group, clinician, or system. BY BANKS is an independent software engineering company; we do not deliver dentistry, we do not make clinical or treatment-planning determinations, we do not direct what is presented to a patient, and we are not a regulated healthcare entity or affiliated with any authority. On any healthcare engagement, the group owns the clinical care, the treatment decisions, the patient relationships, and responsibility for its own compliance. This article is not clinical, commercial, or legal advice; operators should obtain qualified advice for their specific obligations. Public sources used in this piece are listed on our Sources and Data page.
Ready to Build Something?
If this resonated, let's talk about how we can apply these ideas to your business.
Start a Conversation